default author photo

Christine Johnston

University of Washington

Seattle, WA 98195

United States

SCHOLARLY PAPERS

4

DOWNLOADS

368

TOTAL CITATIONS

6

Scholarly Papers (4)

1.

Hydroxychloroquine with or Without Azithromycin for Treatment of Early SARS-CoV-2 Infection Among High-Risk Outpatient Adults: A Randomized Clinical Trial

Number of pages: 43 Posted: 09 Dec 2020
University of Washington, University of Washington - Vaccine and Infectious Disease Division, Division of Allergy and Infectious Diseases, University of Washington, University of Washington - Division of Allergy and Infectious Diseases, School of Public Health and Tropical Medicine, Tulane University, School of Medicine, Tulane University, John H. Stroger, Jr., Hospital of Cook County, John H. Stroger, Jr., Hospital of Cook County, Boston University School of Medicine, Walter Reed Army Institute of Research - Clinical Trials Center, Department of Global Health, University of Washington, Department of Global Health, University of Washington, Department of Global Health, University of Washington, Vaccine and Infectious Disease Division, University of Washington, New York University (NYU) - Grossman School of Medicine, Division of Cardiology, University of Washington, Division of Cardiology, University of Washington, Mayo Clinic, Mayo Clinic, Department of Global Health, University of Washington, Department of Laboratory Medicine and Pathology, University of Washington, University of Washington - Department of Laboratory Medicine and Microbiology, Fred Hutchinson Cancer Research Center - Vaccine and Infectious Disease Division, University of Washington, University of Washington - Department of Medicine, Fred Hutchinson Cancer Research Center - Clinical Research Division, University of Washington - Department of Global Health, University of Washington - Division of Allergy and Infectious Diseases, Division of Allergy and Infectious Diseases, University of Washington, University of Washington - Department of Global Health and Independent
Downloads 131 (554,631)
Citation 2

Abstract:

Loading...

coronavirus, COVID-19, SARS-CoV-2, hydroxychloroquine, azithromycin, early treatment, remote enrollment, randomized controlled trial

2.

First Estimates of the Economic Burden and Quality-of-Life Losses Due to Herpes Simplex Virus Type-2 Infections in Low and Middle-Income Countries – a Modeling Study

Number of pages: 24 Posted: 08 Oct 2021
Harvard University - T.H. Chan School of Public Health, Qatar University, University of Washington, Harvard University - Harvard TH Chan School of Public Health and Cornell University, Qatar - Infectious Diseases Epidemiology Group
Downloads 122 (588,531)

Abstract:

Loading...

Herpes Simplex Virus Type-2, HSV-2, Genital Herpes, HIV, Treatment Costs, Productivity Costs, Quality-of-Life Costs, Economics, Epidemiology

3.

Rapid Decline in Vaccine-Boosted Neutralizing Antibodies Against SARS-CoV-2 Omicron Variant

Number of pages: 57 Posted: 08 Apr 2022
University of Maryland, Baltimore (UMB), Baylor College of Medicine, Fred Hutchinson Cancer Research Center, Fred Hutchinson Cancer Research Center, affiliation not provided to SSRN, affiliation not provided to SSRN, - School of Medicine, Duke University - Duke Human Vaccine Institute, Kaiser Permanente Washington Health Research Institute, University of Rochester - Division of Infectious Diseases, Baylor College of Medicine, Emory University School of Medicine and Children’s Healthcare of Atlanta - Department of Pediatrics, University of Pittsburgh - School of Medicine, University of Washington, University of Texas Medical Branch-Galveston - The Sealy Institute for Vaccine Sciences, New York University (NYU) - Grossman School of Medicine, University of Cincinnati - College of Medicine, Cincinnati Children's Hospital Medical Center - Division of Infectious Diseases, New York University (NYU) - New York University Long Island School of Medicine, New York University (NYU) - Grossman School of Medicine, affiliation not provided to SSRN, University of Pittsburgh - School of Medicine, Emory University - School of Medicine, affiliation not provided to SSRN, Seattle Children’s Research Institute, affiliation not provided to SSRN, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), affiliation not provided to SSRN, University of Washington - Vaccine and Infectious Disease Division, - Center for Vaccine Development and Global Health, affiliation not provided to SSRN, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Emory University - Center for Childhood Infections and Vaccines, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Duke University - Duke Human Vaccine Institute and affiliation not provided to SSRN
Downloads 76 (830,555)
Citation 4

Abstract:

Loading...

COVID-19, SARS-CoV-2, Booster, Vaccine, Omicron variant, B.1.1.529, Neutralizing antibody, mRNA vaccine, recombinant adenovirus vaccine

4.

Pre-Existing Memory B Cell Phenotypes Determine the Quality of B Cell Response to Vaccine Boosters

Number of pages: 31 Posted: 24 Dec 2024
Government of the United States of America - Vaccine Research Center, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, National Institutes of Health - Vaccine Research Center, University of Maryland, Baltimore (UMB), Baylor College of Medicine, - School of Medicine, Kaiser Permanente Washington Health Research Institute, University of Rochester - Division of Infectious Diseases, Emory University School of Medicine and Children’s Healthcare of Atlanta - Department of Pediatrics, University of Pittsburgh - School of Medicine, University of Washington, University of Texas Medical Branch-Galveston - The Sealy Institute for Vaccine Sciences, New York University (NYU) - Grossman School of Medicine, University of Cincinnati - College of Medicine, New York University (NYU) - New York University Long Island School of Medicine, Emory University - School of Medicine, Independent, Fred Hutchinson Cancer Research Center, Government of the United States of America - National Institute of Allergy and Infectious Diseases (NIAID), Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Government of the United States of America - Vaccine Research Center, Independent and Government of the United States of America - Vaccine Research Center
Downloads 39 (1,196,171)

Abstract:

Loading...

SARS-CoV-2 vaccine, prime-boost, B cell phenotype, atypical B cells, single-cell sequencing